A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Study sponsor: Atossa Therapeutics, Inc. · ATOS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-08-13Actual
Enrollment · participants3Actual
Source updated2024-04-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.